NEW DRUG PROTEIN CONJUGATES AND ANTIBODY IMMUNOCONJUGATES (ADC) FOR TARGETED THERAPY USING AI-DRIVEN MACHINE LEARNING.
Summary: New drugs have been spotted to produce drug-antibody immunoconjugates and conjugates to other proteins and molecules for targeted therapy to cancer and other diseases using ai-driven machine learning. Methods for direct production of conjugates with these drugs have been designed using click chemistry and enzymatic ligation reactions.
Fields of the invention: Therapy and diagnosis of cancer and other diseases, biotechnology, pharmacology, immunology, immunotherapy, ai, bioinformatics, machine learning, etc.
We are looking for development partners.
LINKS:
NEW BIOMARKER DISCOVERY AND IDENTIFICATION SYSTEM.
ALGORIMUT©: MUTATION PREDICTION ALGORITHM.
TIME-LAPSE SEQUENTIAL QUANTITATIVE SINGLE-CELL PROTEOMIC ANALYSIS.
NEW DRUG PROTEIN CONJUGATES AND ANTIBODY IMMUNOCONJUGATES (ADC) FOR TARGETED THERAPY.